Log in to save to my catalogue

Expansion of myeloid-derived suppressor cells in patients with severe coronavirus disease (COVID-19)

Expansion of myeloid-derived suppressor cells in patients with severe coronavirus disease (COVID-19)

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2474987483

Expansion of myeloid-derived suppressor cells in patients with severe coronavirus disease (COVID-19)

About this item

Full title

Expansion of myeloid-derived suppressor cells in patients with severe coronavirus disease (COVID-19)

Publisher

London: Nature Publishing Group UK

Journal title

Cell death and differentiation, 2020-11, Vol.27 (11), p.3196-3207

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

SARS-CoV-2 is associated with a 3.4% mortality rate in patients with severe disease. The pathogenesis of severe cases remains unknown. We performed an in-depth prospective analysis of immune and inflammation markers in two patients with severe COVID-19 disease from presentation to convalescence. Peripheral blood from 18 SARS-CoV-2-infected patients...

Alternative Titles

Full title

Expansion of myeloid-derived suppressor cells in patients with severe coronavirus disease (COVID-19)

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2474987483

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2474987483

Other Identifiers

ISSN

1350-9047,1476-5403

E-ISSN

1476-5403

DOI

10.1038/s41418-020-0572-6

How to access this item